|
🦁
|
The Molecular Genetics of Gordon Syndrome
H. Mabillard,
J. Sayer
|
5 |
2019 |
5
🦁
|
|
🐬
|
The Newcastle NHS Chronic Fatigue Syndrome Service: not all fatigue is the same.
J. Newton,
H. Mabillard,
A. Scott,
A. Hoad,
G. Spickett
|
5 |
2010 |
5
🐬
|
|
🐜
|
An intermediate-effect size variant in UMOD confers risk for chronic kidney disease
24 auth.
E. Olinger,
C. Schaeffer,
K. Kidd,
Elhussein A. E. Elhassan,
Yurong Cheng,
I. Dufour,
G. Schiano,
H. Mabillard,
E. Pasqualetto,
Patrick Hofmann,
...
D. Fuster,
A. Kistler,
I. Wilson,
S. Kmoch,
L. Raymond,
Thomas Robert,
K. Eckardt,
A. Bleyer,
A. Köttgen,
P. Conlon,
M. Wiesener,
J. Sayer,
L. Rampoldi,
O. Devuyst
|
4 |
2021 |
4
🐜
|
|
🐜
|
Human urine-derived renal epithelial cells provide insights into kidney-specific alternate splicing variants
15 auth.
E. Molinari,
E. Decker,
H. Mabillard,
J. Tellez,
Shalabh Srivastava,
S. Raman,
K. Wood,
C. Kempf,
S. Alkanderi,
Simon A. Ramsbottom,
...
C. Miles,
Colin A. Johnson,
F. Hildebrandt,
C. Bergmann,
J. Sayer
|
4 |
2018 |
4
🐜
|
|
🦁
|
Electrolyte Disturbances in SARS-CoV-2 Infection
H. Mabillard,
J. Sayer
|
4 |
2020 |
4
🦁
|
|
🦁
|
SGLT2 inhibitors - a potential treatment for Alport syndrome.
H. Mabillard,
J. Sayer
|
4 |
2020 |
4
🦁
|
|
🦁
|
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease
H. Mabillard,
J. Sayer,
E. Olinger
|
4 |
2021 |
4
🦁
|
